查找临床试验
已按「镰状细胞病」检索，对应国际通用词 sickle cell disease
共找到 146 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 00:19，每 5 分钟自动同步Sickle-cell Disease Registry of the GPOH
Germany
年龄 0 Years – 100 Years
University Hospital Heidelberg
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
United States
年龄 18 Years – 70 Years
National Institute of Allergy and Infectious Diseases (NIAID)
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
United States
年龄 18 Years – 不限
RTI International
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
United States、Australia、Belgium、Brazil、Canada 等 12 国
年龄 12 Years – 不限
Novo Nordisk A/S
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
United States、Belgium、Brazil、France、Germany 等 12 国
年龄 10 Years – 65 Years
Sanofi
Blood Sampling for Research Related to Sickle Cell Disease
United States
年龄 18 Years – 100 Years
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
United States
年龄 50 Years – 不限
UConn Health
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
United States
年龄 18 Years – 90 Years
National Heart, Lung, and Blood Institute (NHLBI)
A Long-term Follow-up Study in Patients Who Received BEAM-101
United States
年龄 14 Years – 37 Years
Beam Therapeutics Inc.
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
United States、Canada
年龄 3 Years – 20 Years
University of Rochester
Natural History of Sickle Cell Disease
United States
年龄 2 Years – 90 Years
National Heart, Lung, and Blood Institute (NHLBI)
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
United States
年龄 2 Months – 55 Years
Paul Szabolcs